Ameriprise Financial Inc Cellectis S.A. Transaction History
Ameriprise Financial Inc
- $356 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding CLLS
# of Institutions
30Shares Held
11.7MCall Options Held
0Put Options Held
0-
Long Focus Capital Management, LLC San Juan, PR4.72MShares$7.08 Million0.2% of portfolio
-
B Group, Inc. Dallas, TX3.26MShares$4.88 Million3.46% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.44MShares$2.16 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$2.16 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C3227KShares$340,3120.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $68.3M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...